BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 22403768)

  • 1. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
    Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
    EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An embolic deflection device for aortic valve interventions.
    Nietlispach F; Wijesinghe N; Gurvitch R; Tay E; Carpenter JP; Burns C; Wood DA; Webb JG
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1133-8. PubMed ID: 21087748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of embolic debris captured during transcatheter aortic valve replacement.
    Van Mieghem NM; Schipper ME; Ladich E; Faqiri E; van der Boon R; Randjgari A; Schultz C; Moelker A; van Geuns RJ; Otsuka F; Serruys PW; Virmani R; de Jaegere PP
    Circulation; 2013 Jun; 127(22):2194-201. PubMed ID: 23652860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Front stroke, back stroke: the "emerging" interest of stroke in transcatheter aortic valve implantation.
    Babaliaros VC
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1139-40. PubMed ID: 21087749
    [No Abstract]   [Full Text] [Related]  

  • 10. Embolic protection devices during TAVI - the "proof of the pudding".
    Van Mieghem NM; Serruys PW
    EuroIntervention; 2012 May; 8(1):25-9. PubMed ID: 22433129
    [No Abstract]   [Full Text] [Related]  

  • 11. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.
    Treede H; Mohr FW; Baldus S; Rastan A; Ensminger S; Arnold M; Kempfert J; Figulla HR
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e131-8. PubMed ID: 22508111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Protection During MitraClip Implantation: Initial Experience at 2 Centers.
    Frerker C; Schlüter M; Sanchez OD; Reith S; Romero ME; Ladich E; Schröder J; Schmidt T; Kreidel F; Joner M; Virmani R; Kuck KH
    JACC Cardiovasc Interv; 2016 Jan; 9(2):171-9. PubMed ID: 26723763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sentinel in Mitraclip intervention: Catch the enemy!
    Calcagno S; Cimino S; Cerbelli B; Sardella G
    Catheter Cardiovasc Interv; 2019 May; 93(6):E346-E348. PubMed ID: 30286525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral events and protection during transcatheter aortic valve replacement.
    Freeman M; Barbanti M; Wood DA; Ye J; Webb JG
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):885-96. PubMed ID: 24550141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.
    Van Mieghem NM; El Faquir N; Rahhab Z; Rodríguez-Olivares R; Wilschut J; Ouhlous M; Galema TW; Geleijnse ML; Kappetein AP; Schipper ME; de Jaegere PP
    JACC Cardiovasc Interv; 2015 Apr; 8(5):718-24. PubMed ID: 25946445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
    Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
    Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
    Haussig S; Mangner N; Dwyer MG; Lehmkuhl L; Lücke C; Woitek F; Holzhey DM; Mohr FW; Gutberlet M; Zivadinov R; Schuler G; Linke A
    JAMA; 2016 Aug; 316(6):592-601. PubMed ID: 27532914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good?
    Praz F; Nietlispach F
    EuroIntervention; 2013 Sep; 9 Suppl():S124-8. PubMed ID: 24025951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.